Pharsight

Drugs that contain Aliskiren Hemifumarate; Valsartan

1. Valturna patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8168616 NOVARTIS Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
Jul, 2026

(2 years from now)

Market Authorisation Date: 16 September, 2009

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

VALTURNA family patents

Family Patents